Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01592188 · ClinicalTrials.gov registry record · Phase 3
Cognitively-Based Compassion Training and Mindfulness Attention Training Program
A Phase 3 study of Behavioral Resilience and Biological Resilience, sponsored by Emory University.
- Completed
- Registry status
- Phase 3
- Development phase
- 53
- Enrollment target
- 1
- Study location
NCT01592188: Completed Phase 3 study of Behavioral Resilience and Biological Resilience, sponsored by Emory University.
NCT01592188 is a Phase 3 study of Behavioral Resilience and Biological Resilience that has completed, run by Emory University. The registered enrollment target is 53 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01592188, a Phase 3 study of Behavioral Resilience and Biological Resilience, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 53 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will explore the effect of Cognitively-Based Compassion Training or mindfulness training on behavior and saliva stress hormones in elementary school-age children.
Primary Outcome
Assessments before and after CBCT or MT interventions will be conducted to see if these practices lead to changes in interpersonal behavior. Participants will be asked to respond to questions related to social behavior in the lab setting, with the Social Circle Task, Mind In The Eyes Task, and the Implicit Association Task.
Conditions Studied
Interventions
- BEHAVIORAL Mindfulness training
- BEHAVIORAL Cognitively-Based Compassion Training (CBCT)
Study Locations (1)
Georgia
- Paideia School - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2012-01 |
| Est. Completion | 2013-11 |
| Phase | Phase 3 |
What the finished NCT01592188 record still lists
NCT01592188 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 53 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Behavioral Resilience appearing as the primary indexed condition, and to 2 interventions - of which Mindfulness training is the first listed.
NCT01592188 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT01592188 about?
NCT01592188 is a clinical study titled "Cognitively-Based Compassion Training and Mindfulness Attention Training Program". This project will explore the effect of Cognitively-Based Compassion Training or mindfulness training on behavior and saliva stress hormones in elementary school-age children.
What is the current status of trial NCT01592188?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 53 participants. The study started on 2012-01. Estimated completion is 2013-11.
What conditions does trial NCT01592188 study?
This clinical trial studies the following conditions: Behavioral Resilience, Biological Resilience.
What interventions are being tested in trial NCT01592188?
The interventions under investigation include: Mindfulness training (BEHAVIORAL), Cognitively-Based Compassion Training (CBCT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01592188?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01592188 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01592188's enrollment target sits among peer trials
53 1839th of 2000 higher than 160 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia